VISTULENT

This brand name is authorized in Nigeria.

Active ingredients

The drug VISTULENT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 1C4QK22F9J - POTASSIUM IODIDE
 

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.
 
Read more about Potassium iodide
2
Sodium iodide
UNII F5WR8N145C - SODIUM IODIDE

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-7783 Eye drops Vistulent Eye Drop Potassium Iodide, Sodium Iodide SOL_DROPS 0.3%; 0.3% 1 x 10 mL (in bottle) Ophthalmic Liquid 2 RNW-PP-311144 VISTULENT EYE DROP POTASSIUM IODIDE, SODIUM IODIDE Potassium iodide 2.40kg, Sodium iodide 2.40kg, Sodium chloride 1.78kg, Boric acid 9.84kg, Sodium borate 0.40kg, Disodium edetate 0.80kg, Chlorhexidine acetate 0.08kg, Hypromellose E4m premium 0.20kg, Water for injection to 800.00L Apr-83 Drugs Nigerian Products X10ml POM 1 2/1/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria 28/09/2023

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-7783

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈